Drug Discovery 2017 London, England, UK 27-28 March 2017

Description:
SMi proudly presents its exclusive conference on Drug Discovery, taking place on 27th & 28th March 2017.

In recent years, the Pharma/Biotech industry has undergone radical changes which have increased are understanding of drug discovery and development, however there are still many hurdles that the industry face.

The gap between a laboratory discovery and an approved drug on the market is a decade-long process of laboratory testing, evaluation in animal models and human clinical trials that can cost hundreds of millions. The conference aims to bridge the gaps in approval for drug discovery and development by discussing the latest scientific breakthroughs, exploring novel technologies and approaches that can be used to overcome drug development challenges.

The conference will bring together industry leaders who will highlight future opportunities for novel therapeutic discovery. Some of our featured speakers include

Lorenz Mayr, VP & Global Head, AstraZeneca

Guido Hanaeur, Scientific Director Translational Medicine, Takeda

Time: 8:30 am to 4:30 pm

Prices:
Book by 30 November 2016: GBP 1099,
Book by 16 December 2016: GBP 1299,
Book by 31 January 2016: GBP 1399,
Standard Ticket: GBP 1499

Speakers: Sanofi, AbbVie, Takeda California, Takeda Pharmaceuticals, Eli Lilly, Merck Serono, Novartis, GlaxoSmithKline, Johnson & Johnson, Heptares, University of York